Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (14)

2023

  1. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2020

  1. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

2019

  1. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  2. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2018

  1. Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells

    Stem Cells, Vol. 36, Núm. 10, pp. 1487-1500

2016

  1. Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers

    Nature Communications, Vol. 7

2014

  1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells

    Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148

  2. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia

    Nature Communications, Vol. 5

2013

  1. DNA methylation signatures identify biologically distinct thyroid cancer subtypes

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821

2012

  1. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

  2. The transcription factor CREBZF is a novel positive regulator of p53

    Cell Cycle, Vol. 11, Núm. 20, pp. 3887-3895

2010

  1. HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

    Oncogene, Vol. 29, Núm. 3, pp. 411-420

  2. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 366-372

2009

  1. Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out

    Cancer Research, Vol. 69, Núm. 8, pp. 3650-3656